In international news, India has approved two vaccines against COVID-19: the Oxford-AstraZeneca vaccine and Bharat Biotech’s domestically developed Covaxin. Indian health experts and politicians expressed alarm that Covaxin was approved without any published data on its efficacy. India aims to inoculate 300 million frontline workers, elderly and vulnerable people, out of its 1.35 billion population, by August.
Britain became the first country today to start administering doses of the Oxford-AstraZeneca vaccine.
In related news, the World Health Organization listed Pfizer-BioNTech’s COVID-19 vaccine for emergency use Thursday, which should allow less wealthy countries to expedite their own regulatory approval process for the treatment.